Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 01-2004 | 12-2003 | 01-2003 | 12-2002 | |
| Sales | 1,229 | 31,113 | 657 | 25,672 | 904 |
| Cost of Goods | 2,112 | 22,494 | 502 | 16,783 | N/A |
| Gross Profit | -883 | 8,619 | 155 | 8,889 | 904 |
| Operating Expenses | 10,118 | 8,915 | 7,909 | 8,559 | 6,961 |
| Operating Income | -10,889 | 198 | -7,252 | 1,113 | -6,057 |
| Interest Expense | 384 | 169 | 253 | 207 | 0 |
| Other Income | -4,868 | 48 | -6,488 | 78 | 1,573 |
| Pre-tax Income | -16,141 | 77 | -13,993 | 984 | -4,484 |
| Income Tax | N/A | -465 | N/A | -22 | N/A |
| Net Income Continuous | -16,141 | 542 | -13,993 | 1,006 | -4,484 |
| Net Income | $-16,887 | $542 | $-13,993 | $1,006 | $-4,484 |
| EPS Basic Total Ops | -24,326.91 | 0.14 | -21,153.84 | 0.26 | -12,163.46 |
| EPS Basic Continuous Ops | -18,894.38 | 0.14 | -21,002.24 | 0.26 | -7,390.59 |
| EPS Diluted Total Ops | -24,326.91 | 0.14 | -21,153.84 | 0.26 | -12,163.46 |
| EPS Diluted Continuous Ops | -18,894.38 | 0.14 | -21,002.24 | 0.26 | -7,390.59 |
| EBITDA(a) | $-5,159 | $1,023 | $2,066 | $2,016 | $-5,760 |